Jenna Hebert is an Investment Director on the Venture Team at RA Capital Management. Jenna primary responsibility is to conduct due diligence on biotechnology companies at RA Capital and serve as a board director for Alchemab Therapeutics and a stealth RA Capital portfolio company. Prior to RA Capital, Jenna was an Analyst and Medical Writer at Costello Medical Consulting. Jenna has a BA in Neuroscience from University of Pennsylvania and a PhD in Neuroscience from the University of Oxford